0001127602-22-020666 | 4 | Charles River Laboratories International, Inc.

Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

SEC Filings

Document Details

Form

Filing Date

Aug 8, 2022

Document Date

Jul 6, 2022

Form Description

Statement of changes in beneficial ownership of securities

Filing Group

3,4,5

Company

Charles River Laboratories International, Inc.

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Filer

LaPlume Joseph W

Filing Formats

View HTML

Download PDF

Download DOC

Download XLS

Investor Relations

SEC Filings

Document Details

Filing Formats

Stock Quote

Featured Report